Trial intelligence / Profile preview

Amlodipine for Uterine Pulsatility Index in Frozen Embryo Transfer

NCT04954196Phase 2Withdrawn

Sponsor
CHU Montpellier
Start
Oct 2021
Primary completion
Oct 2023
Modality
Small Molecules
01

Overview

A Phase 2 trial of amlodipine in uterine ischemia, sponsored by CHU Montpellier. Planned start Oct 2021; status: withdrawn.

02

Drugs

amlodipine
03

Conditions

uterine ischemia

Beyond the preview

Go deeper on NCT04954196.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04954196.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call